These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29760666)

  • 1. Candyflipping and Other Combinations: Identifying Drug-Drug Combinations from an Online Forum.
    Chary M; Yi D; Manini AF
    Front Psychiatry; 2018; 9():135. PubMed ID: 29760666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees.
    Mohr ALA; Friscia M; Yeakel JK; Logan BK
    Forensic Sci Int; 2018 Jan; 282():168-178. PubMed ID: 29216523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
    Soussan C; Kjellgren A
    Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
    Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
    Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia.
    Darke S; Duflou J; Peacock A; Farrell M; Lappin J
    Drug Alcohol Depend; 2019 Nov; 204():107556. PubMed ID: 31546120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Fluoramphetamine in the Netherlands: Text-mining and sentiment analysis of internet forums.
    Blankers M; van der Gouwe D; van Laar M
    Int J Drug Policy; 2019 Feb; 64():34-39. PubMed ID: 30551004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring new psychoactive substances: Exploring the contribution of an online discussion forum.
    Rhumorbarbe D; Morelato M; Staehli L; Roux C; Jaquet-Chiffelle DO; Rossy Q; Esseiva P
    Int J Drug Policy; 2019 Nov; 73():273-280. PubMed ID: 30967328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
    Schifano F; Papanti GD; Orsolini L; Corkery JM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelic Fauna for Psychonaut Hunters: A Mini-Review.
    Orsolini L; Ciccarese M; Papanti D; De Berardis D; Guirguis A; Corkery JM; Schifano F
    Front Psychiatry; 2018; 9():153. PubMed ID: 29910745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomedical analysis of New Psychoactive Substances (NPS) of natural origin.
    Lo Faro AF; Di Trana A; La Maida N; Tagliabracci A; Giorgetti R; Busardò FP
    J Pharm Biomed Anal; 2020 Feb; 179():112945. PubMed ID: 31704129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic cathinones: an evolving class of new psychoactive substances.
    Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS
    Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Experiments with Psychoactive Substances: A Historical Perspective.
    Passie T; Brandt SD
    Handb Exp Pharmacol; 2018; 252():69-110. PubMed ID: 30478735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
    Licht CL; Christoffersen M; Okholm M; Damgaard L; Fink-Jensen A; Knudsen GM; Erritzoe D
    Hum Psychopharmacol; 2012 Jul; 27(4):352-63. PubMed ID: 22696164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
    Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
    Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.
    Palamar JJ; Barratt MJ; Ferris JA; Winstock AR
    Am J Addict; 2016 Aug; 25(5):400-7. PubMed ID: 27419383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New psychoactive substances: a review and updates.
    Shafi A; Berry AJ; Sumnall H; Wood DM; Tracy DK
    Ther Adv Psychopharmacol; 2020; 10():2045125320967197. PubMed ID: 33414905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
    van der Gouwe D; Brunt TM; van Laar M; van der Pol P
    Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.
    Lamy FR; Daniulaityte R; Nahhas RW; Barratt MJ; Smith AG; Sheth A; Martins SS; Boyer EW; Carlson RG
    Int J Drug Policy; 2017 Jun; 44():121-129. PubMed ID: 28578250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing self-reported use of new psychoactive substances: The impact of gate questions.
    Palamar JJ; Acosta P; Calderón FF; Sherman S; Cleland CM
    Am J Drug Alcohol Abuse; 2017 Sep; 43(5):609-617. PubMed ID: 28485987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.